- About ABC
- Contact Us
The ABC has established the Innovation Initiative (ABCI2), a collaborative program to stimulate private investment in brain-related research and strengthen the entire research and development system for expedited translation of neuroscience research into life changing therapies and cures. This ABC advocacy effort is comprised of key stakeholders within the brain community, including patient advocacy groups, organizations representing health professionals, and pharmaceutical research and manufacturers, collaborating to advance policy positions, legislation and regulations that will strengthen the incentives of for-profit entities to invest in neuroscience research – positively impacting brain disorders.
The goals and objectives of the American Brain Coalition Innovation Initiative (ABCI2) is to:
The ABC will generate needed information to build the strongest case possible for solutions, whether they be educational, legislative, or regulatory in nature, that will incentivize an increase in private sector investment in research and development.
By leveraging the existing infrastructure, the ABC has expanded its focus to generate and disseminate a higher volume and quality of information related to the need for private investment in neuroscience research. This focused effort will amplify existing elements of our successful, multi-dimensional issue-advocacy campaign.
“The ABC is grateful to our industry partners who continue to champion translational
and clinical neuroscience research and desire to see their work continue
and grow for many years to come.” Robin Elliott, ABCI2 Chair